Oncology Information System Market Key Players Analysis and Growth to reach $11.1 billion by 2027

The global Oncology Information System Market in terms of revenue was estimated to be worth $7.7 billion in 2022 and is poised to reach $11.1 billion by 2027, growing at a CAGR of 7.6% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market includes software's and services used for comprehensive information and image management that facilitates in the management and optimization of cancer patient profiles & treatment. Patient portfolios are managed by software known as electronic health record (EHR) in healthcare settings such as clinics, hospitals, and research laboratories. These software's are used to predict treatment outcomes, plan treatment, and exchange cancer patient information across healthcare organizations. These benefits improve the safety and efficacy of cancer treatment for patients. Oncology information system assists physicians and surgeons in selecting the most appropriate therapy to improve the survival rates of cancer patients.

Download a FREE Sample Report PDF of the Global Oncology Information System Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1721676&utm_source=Ganesh&utm_medium=P

Prominent players in the oncology information system market are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US), IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).

The growth of this market is primarily driven by factors such as increasing incidence and prevalence of cancer and increasing need to curtail the cost of cancer care and potential benefits offered by oncology information system in treatment, management, and planning for cancer care.

This study categorizes the global oncology information system market to forecast revenue and analyze trends in each of the following submarkets:
By Product and Service
• Software
• Patient Information Systems
• Radiology Information systems
• Oncology Electronic Medical Record (EHR)
• Laboratory Information Systems
• Chemotherapy Information System
• Treatment Planning Systems
• Clinical Decision Support Systems
• Radiotherapy Treatment Planning Systems
• Brachytherapy Treatment Planning Systems
• Treatment Management Systems & Medical Image Analysis Systems
• Population Health Management
• Clinical Integration Solutions
• Picture archiving and communication System (PACS) & VNA
• Advanced Visualization & Image Analysis Solutions
• Radiation Dose Management Solutions
• Professional Services
• Consulting/Optimization Services
• Implementation Services
• Post-Sale and Maintenance Services

By Application
• Radiation Oncology
• Medical Oncology
• Surgical Oncology

By End User
• Hospitals & Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Software to account for the largest share of the oncology information system industry during the forecast period
In 2021, the software segment accounted for 83.6% of the oncology information system market for products and services in 2021. The high share of this market segment can be attributed primarily to growing need to control the rising oncology care costs and improve the efficiency of oncology care services by reducing medical errors. Softwares are integral part of any oncology information system and works as interface between database and end user.

Radiation oncology to account for the largest share of the oncology information system industry during the forecast period
The oncology information system market for applications is segmented into radiation oncology, medical oncology and surgical oncology. The radiation oncology segment accounted for 53.8% of the market in 2021. The demand for radiation oncology has increased due to increase in the number of radiosurgeries, and a large volume of cancer-related data is being generated at radiological departments.

Direct Purchase of the Global Oncology Information System Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=1721676&utm_source=Ganesh&utm_medium=P

Hospitals & Diagnostic Imaging Centers to account for the largest share of the oncology information system industry during the forecast period
The oncology information system market by end user is segmented into hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions and research facilities. The hospitals & diagnostic imaging centers held the largest share of the in-application segment of market. The increasing adoption of oncology information system at hospital and diagnostic imaging centers due to large amount of data generated during diagnosis and treatment of cancer and significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems are some of the factors responsible for the growth of this segment.

The APAC oncology information system industry is projected to grow at the highest rate during the forecast period.
In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the rising prevalence of cancer, and increasing investment for implementation of IT solutions in healthcare settings. For instance, according to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road Suite 430 Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

MarketsandMarkets was founded in 2009 with a simple, yet powerful, idea - every disruption is inherently the source of game-changing business opportunities. At that time, everybody was talking about disruptive trends such as AI, IoT, 3D printing, nanotech, robotics, etc. but nobody was certain about the business opportunities associated with them. Upon sensing this significant white space, MarketsandMarkets started exploring these emerging and fast-growing opportunities and soon realized that it was part of a much bigger game. We figured out that the B2B economy was just beginning to undergo a dramatic transformation, wherein roughly $25 trillion of new revenue sources would emerge by the end of 2030. So, we embarked on a journey to help B2B companies monetize their play in this phenomenon.

This release was published on openPR.